Index
1 Market Overview of Nanomedicines
1.1 Nanomedicines Market Overview
1.1.1 Nanomedicines Product Scope
1.1.2 Nanomedicines Market Status and Outlook
1.2 Global Nanomedicines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanomedicines Market Size by Region (2018-2029)
1.4 Global Nanomedicines Historic Market Size by Region (2018-2023)
1.5 Global Nanomedicines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanomedicines Market Size (2018-2029)
1.6.1 North America Nanomedicines Market Size (2018-2029)
1.6.2 Europe Nanomedicines Market Size (2018-2029)
1.6.3 Asia-Pacific Nanomedicines Market Size (2018-2029)
1.6.4 Latin America Nanomedicines Market Size (2018-2029)
1.6.5 Middle East & Africa Nanomedicines Market Size (2018-2029)
2 Nanomedicines Market by Type
2.1 Introduction
2.1.1 Nanoparticles
2.1.2 Nanoshells
2.1.3 Nanotubes
2.1.4 Nanodevices
2.1.5 Others
2.2 Global Nanomedicines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanomedicines Historic Market Size by Type (2018-2023)
2.2.2 Global Nanomedicines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanomedicines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanomedicines Revenue Breakdown by Type (2018-2029)
3 Nanomedicines Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Research Institute
3.2 Global Nanomedicines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanomedicines Historic Market Size by Application (2018-2023)
3.2.2 Global Nanomedicines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanomedicines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanomedicines Revenue Breakdown by Application (2018-2029)
4 Nanomedicines Competition Analysis by Players
4.1 Global Nanomedicines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanomedicines as of 2022)
4.3 Date of Key Players Enter into Nanomedicines Market
4.4 Global Top Players Nanomedicines Headquarters and Area Served
4.5 Key Players Nanomedicines Product Solution and Service
4.6 Competitive Status
4.6.1 Nanomedicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott Nanomedicines Products, Services and Solutions
5.1.4 Abbott Nanomedicines Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 GE Healthcare
5.2.1 GE Healthcare Profile
5.2.2 GE Healthcare Main Business
5.2.3 GE Healthcare Nanomedicines Products, Services and Solutions
5.2.4 GE Healthcare Nanomedicines Revenue (US$ Million) & (2018-2023)
5.2.5 GE Healthcare Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Nanomedicines Products, Services and Solutions
5.3.4 Johnson & Johnson Nanomedicines Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Nanomedicines Products, Services and Solutions
5.4.4 Merck Nanomedicines Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Nanomedicines Products, Services and Solutions
5.5.4 Pfizer Nanomedicines Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 CombiMatrix
5.6.1 CombiMatrix Profile
5.6.2 CombiMatrix Main Business
5.6.3 CombiMatrix Nanomedicines Products, Services and Solutions
5.6.4 CombiMatrix Nanomedicines Revenue (US$ Million) & (2018-2023)
5.6.5 CombiMatrix Recent Developments
5.7 Celgene
5.7.1 Celgene Profile
5.7.2 Celgene Main Business
5.7.3 Celgene Nanomedicines Products, Services and Solutions
5.7.4 Celgene Nanomedicines Revenue (US$ Million) & (2018-2023)
5.7.5 Celgene Recent Developments
5.8 Mallinckrodt
5.8.1 Mallinckrodt Profile
5.8.2 Mallinckrodt Main Business
5.8.3 Mallinckrodt Nanomedicines Products, Services and Solutions
5.8.4 Mallinckrodt Nanomedicines Revenue (US$ Million) & (2018-2023)
5.8.5 Mallinckrodt Recent Developments
5.9 Sigma-Tau Pharmaceuticals
5.9.1 Sigma-Tau Pharmaceuticals Profile
5.9.2 Sigma-Tau Pharmaceuticals Main Business
5.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Products, Services and Solutions
5.9.4 Sigma-Tau Pharmaceuticals Nanomedicines Revenue (US$ Million) & (2018-2023)
5.9.5 Sigma-Tau Pharmaceuticals Recent Developments
5.10 Teva Pharmaceutical
5.10.1 Teva Pharmaceutical Profile
5.10.2 Teva Pharmaceutical Main Business
5.10.3 Teva Pharmaceutical Nanomedicines Products, Services and Solutions
5.10.4 Teva Pharmaceutical Nanomedicines Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceutical Recent Developments
5.11 Nanosphere
5.11.1 Nanosphere Profile
5.11.2 Nanosphere Main Business
5.11.3 Nanosphere Nanomedicines Products, Services and Solutions
5.11.4 Nanosphere Nanomedicines Revenue (US$ Million) & (2018-2023)
5.11.5 Nanosphere Recent Developments
5.12 UCB SA
5.12.1 UCB SA Profile
5.12.2 UCB SA Main Business
5.12.3 UCB SA Nanomedicines Products, Services and Solutions
5.12.4 UCB SA Nanomedicines Revenue (US$ Million) & (2018-2023)
5.12.5 UCB SA Recent Developments
6 North America
6.1 North America Nanomedicines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanomedicines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanomedicines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanomedicines Market Dynamics
11.1 Nanomedicines Industry Trends
11.2 Nanomedicines Market Drivers
11.3 Nanomedicines Market Challenges
11.4 Nanomedicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List